The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach
Sponsor: MSD Belgium BVBA
Listed as NCT03643913, this PHASE4 trial focuses on Anesthesia and Shoulder Pain and remains completed. Sponsored by MSD Belgium BVBA, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Jan 2025 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed
-
Sep 2024 — Jan 2025 [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Jul 2024 [monthly]
Recruiting PHASE4
-
Oct 2021 — Sep 2022 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Feb 2019 — Dec 2019 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MSD Belgium BVBA
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .